Watchlist

Watchlist
Applied Genetic Technologies Corpor... (AGTC)
Applied Genetic Technologies Corpor... (AGTC)
MeiraGTx Aims For $86 Million U.S. IPO
Quick Take MeiraGTx ( MGTX ) intends to raise $86.25 million from the sale of its common stock in an IPO, according to a registration statement filed with the SEC. The firm is a clinical stage developer of gene therapies focused on diseases of the eye, salivary gland and central nervou…
Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q3 2018 Results - Earnings Call Transcript
Applied Genetic Technologies Corporation (AGTC) Q3 2018 Earnings Conference Call May 08, 2018 04:30 PM ET Executives Sue Washer - Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Yanan Zhu - Wells Fargo Pete Sta…
Applied Genetic misses by $0.04, misses on revenue
Applied Genetic (NASDAQ: AGTC ): Q3 EPS of -$0.45 misses by $0.04 . Revenue of $3.6M (-57.1% Y/Y) misses by $1.97M . Shares -1% . Press Release More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, ,
Notable earnings after Tuesday's close
AAOI , AAXN , AGTC , ALEX , AMBC , APEI , ARNA , AVD , BECN , BIO , BOJA , BW , CA , CERS , CHUY , CISN , CLVS , CORT , CSOD , CTRE , CUTR , CVG , DEI , DIOD , DIS , DVAX , DXPE , EA , ECPG , EPR , ESE , ESIO , ETSY , EVC , EXTR , FANG , FARM , FOSL , …
Finding Biotech Value In All-Time Highs
Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes…
Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript
Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B…
Applied Genetic EPS of -$0.29
Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more …
After Hours Gainers / Losers
Top gainers: DCIX +23.6% . DDR +10.6% . HES +6.1% . QNST +5.1% . RIGL +5.0% . More news on: Diana Containerships Inc., DDR Corp., Hess Corporation, Stocks on the move, Read more …
Editors' Picks Daily: Is Downsizing A Fad?
Note: Subscribers to SA Editors' Picks Plus got an early look at this article. Each article listed below has been selected by our editorial staff as a widely appealing and highly convincing analysis with a clear actionable takeaway. Please use the comment box at the end of this article to …
Applied Genetic Technologies Corp.: A Forgotten Net-Net With Clear Upside Catalysts
Applied Genetic Technologies Corp. ( AGTC ) is a clinical stage biotech company developing therapies for patients with inherited diseases. AGTC has developed a proprietary gene therapy platform that the company has initially used to focus on ophthalmology. AGTC has initially targeted orphan …
Applied Genetic Technologies Corpor... (AGTC)
Applied Genetic Technologies Corpor... (AGTC)